233 related articles for article (PubMed ID: 21575980)
21. Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b.
Hedjran F; Shantanu K; Tony R
Cancer Gene Ther; 2011 Oct; 18(10):717-23. PubMed ID: 21818136
[TBL] [Abstract][Full Text] [Related]
22. Selective effects of E1B-defective adenoviruses and adenovirus E1A mutants in deficient mouse primary embryonic fibroblasts.
Martin Duque P; Parada C; Guinea J; Sanchez-Prieto R; Ramon Y Cajal S
Int J Oncol; 2001 Jun; 18(6):1163-7. PubMed ID: 11351246
[TBL] [Abstract][Full Text] [Related]
23. Genetically modified adenoviruses against gliomas: from bench to bedside.
Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.
Krömmelbein N; Wiebusch L; Schiedner G; Büscher N; Sauer C; Florin L; Sehn E; Wolfrum U; Plachter B
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848680
[TBL] [Abstract][Full Text] [Related]
25. Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
Sauthoff H; Pipiya T; Chen S; Heitner S; Cheng J; Huang YQ; Rom WN; Hay JG
Cancer Gene Ther; 2006 Jul; 13(7):686-95. PubMed ID: 16470212
[TBL] [Abstract][Full Text] [Related]
26. Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.
Doloff JC; Jounaidi Y; Waxman DJ
Cancer Gene Ther; 2011 Mar; 18(3):153-66. PubMed ID: 20865021
[TBL] [Abstract][Full Text] [Related]
27. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.
Jiang H; Gomez-Manzano C; Alemany R; Medrano D; Alonso M; Bekele BN; Lin E; Conrad CC; Yung WK; Fueyo J
Neoplasia; 2005 Jan; 7(1):48-56. PubMed ID: 15720816
[TBL] [Abstract][Full Text] [Related]
28. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
Savelyeva I; Dobbelstein M
Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
[TBL] [Abstract][Full Text] [Related]
29. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
[TBL] [Abstract][Full Text] [Related]
30. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.
Baird SK; Aerts JL; Eddaoudi A; Lockley M; Lemoine NR; McNeish IA
Oncogene; 2008 May; 27(22):3081-90. PubMed ID: 18071311
[TBL] [Abstract][Full Text] [Related]
31. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
32. Development of novel E1-complementary cells for adenoviral production free of replication-competent adenovirus.
Farson D; Tao L; Ko D; Li Q; Brignetti D; Segawa K; Mittelstaedt D; Harding T; Yu DC; Li Y
Mol Ther; 2006 Aug; 14(2):305-11. PubMed ID: 16697707
[No Abstract] [Full Text] [Related]
33. Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery.
Kemp V; Dautzenberg IJC; Limpens RW; van den Wollenberg DJM; Hoeben RC
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934149
[TBL] [Abstract][Full Text] [Related]
34. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
[TBL] [Abstract][Full Text] [Related]
35. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
O'Shea CC; Johnson L; Bagus B; Choi S; Nicholas C; Shen A; Boyle L; Pandey K; Soria C; Kunich J; Shen Y; Habets G; Ginzinger D; McCormick F
Cancer Cell; 2004 Dec; 6(6):611-23. PubMed ID: 15607965
[TBL] [Abstract][Full Text] [Related]
36. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
Hobom U; Dobbelstein M
J Virol; 2004 Jul; 78(14):7685-97. PubMed ID: 15220443
[TBL] [Abstract][Full Text] [Related]
37. Smarter viruses. Onyx pharmaceuticals, Inc.
Wells WA
Chem Biol; 2000 Dec; 7(12):R223-4. PubMed ID: 11137823
[No Abstract] [Full Text] [Related]
38. Adenovirus's last trick: you say lysis, we say autophagy.
Jiang H; White EJ; Gomez-Manzano C; Fueyo J
Autophagy; 2008 Jan; 4(1):118-20. PubMed ID: 18032923
[TBL] [Abstract][Full Text] [Related]
39. Oncolytic E1B 55KDa-deleted adenovirus replication is independent of p53 levels in cancer cells.
Abbas BM; El-Mogy MA; Haj-Ahmad Y
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(7):1-11. PubMed ID: 28838332
[TBL] [Abstract][Full Text] [Related]
40. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]